Gene-environmental interactions and organophosphate toxicity

Toxicology

Volumn 278, Issue 3, 2010, Pages 294-304

  Povey, Andrew C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CYP; Organophosphate; Paraoxonase; Sheep dip; Susceptibility

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; BROMOPHOS; CARBOFENOTION; CHLORPYRIFOS; CHOLINESTERASE; COUMAFOS; CYTOCHROME P450; DICHLOFENTHION; DIMPYLATE; DIOXATION; FENCLOFOS; IODOFEPHOS; ORGANOPHOSPHATE PESTICIDE; PYRIMITHATE; UNCLASSIFIED DRUG;

AGRICULTURAL WORKER; AMINO ACID SUBSTITUTION; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE INTERACTION; HUMAN; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SHEEP;

ANIMAL HUSBANDRY; ANIMALS; ARYLDIALKYLPHOSPHATASE; ECTOPARASITIC INFESTATIONS; ENVIRONMENTAL POLLUTANTS; GENETIC PREDISPOSITION TO DISEASE; INSECTICIDES; OCCUPATIONAL EXPOSURE; ORGANOPHOSPHORUS COMPOUNDS; POLYMORPHISM, GENETIC; SHEEP; SHEEP DISEASES;

MUS; OVIS ARIES;

EID: 78649726020     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.02.007     Document Type: Review

References (84)

1. Ahmed G.M., Davies D.R. Chronic organophosphate exposure: toward the definition of a neuropsychiatric syndrome. J. Nutr. Environ. Med. 1997, 7:169-176.
2. Appraisal Panel for Human Suspected Adverse Reactions to Veterinary and Medicines Annual Report for 2004 2004, http://www.vpc.gov.uk/Public/AR/vpcapar04.pdf.
3. Benmoyal-Segal L., Vander T., Shifman S., Bryk B., Ebstein R., Marcus E.-L., Stessman J., Darvasi A., Herishanu Y., Friedman A., Soreq H. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. FASEB J. 2005, 19:452-454.
4. Berkowitz G.S., Wetmur J.G., Birman-Deych E., Obel J., Lapinski R.H., Godbold J.H., Holzman I.R., Wolff M.S. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ. Health Perspect. 2004, 112:388-391.
5. Botto L.D., Khoury M.J. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am. J. Epidemiol. 2001, 153:1016-1020.
6. Bowen H.M., Cutler J.R., Craigie I.R. A survey of sheep dip usage in Scotland in 1978. Pestic. Sci. 1982, 13:563-574.
7. Brophy V.H., Jampsa R.L., Clendenning J.B., McKinstry L.A., Jarvik G.P., Furlong C.E. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am. J. Hum. Genet. 2001, 68:1428-1436.
8. Brown T.P., Rumsby P.C., Capleton A.C., Rushton L., Levy L.S. Pesticides and Parkinson's disease-is there a link?. Environ. Health Perspect. 2006, 114:156-164.
9. Buchanan D., Pilkington A., Sewell C., Tannahill S.N., Kidd M.W., Cherrie B., Hurley J.F. Estimation of cumulative exposure to organophosphate sheep dips in a study of chronic neurological health effects among United Kingdom sheep dippers. Occup. Environ. Med. 2001, 58:694-701.
10. Buratti F.M., Volpe M.T., Meneguz A., Vittozzi L., Testai E. CYP-specific bioactivation of four organophosphate pesticides by human liver microsomes. Toxicol. Appl. Pharmacol. 2003, 186:143-154.
11. Cherry N.M., Mackness M., Durrington P., Povey A.C., Dippnall W.M., Smith A.E., Mackness B. Paraoxonase (PON1) polymorphisms in farmers attributing ill-health to sheep dip. Lancet 2002, 359:763-764.
12. Cherry N.M., Durrington P.N., Mackness B., Mackness M.I., Smith A.E., Dippnall W.M., Povey A.C. Genetic variation in susceptibility to chronic effects of organophosphate exposure. HSE Res. Rep. 2005, 408. http://hse.gov.uk/research/rrpdf/rr408.pdf.
13. Cocker J., Mason H.J., Garfitt S.J., Jones K. Biological monitoring of exposure to organophosphate pesticides. Toxicol. Lett. 2002, 134:97-103.
14. Cole T.B., Walter B.J., Shih D.M., Tward A.D., Lusis A.J., Timchalk C., Richter R.J., Costa L.G., Furlong C.E. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet. Genomics 2005, 15:589-598.
15. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment Organophosphates 1999, Department of Health, London.
16. Costa L.G., Richter R.J., Li W.-F., Cole T., Guizzetti M., Furlong C.E. Paraoxonase (PON1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 2003, 8:1-12.
17. Costa L.G., Vitalone A., Cole T.B., Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 2005, 69:541-550.
18. Cutler J.R. A survey of sheep dip usage in Scotland in 1973. Pestic. Sci. 1975, 6:617-627.
19. Dai D., Tang J., Rose R., Hodgson E., Bienstock R.J., Mohrenweiser H.W., Goldstein J.A. Identification of variants of CYP3A4 and characterisation of their abilities to metabolize testosterone and chlorpyrifos. J. Pharmacol. Exp. Ther. 2001, 299:825-831.
20. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 1996, 14:334-336.
21. Dick F.D., de Palma G., Ahmadi A., Osborne A., Scott N.W., Prescott G.J., Bennett J., Semple S., Dick S., Mozzoni P., Haites N., Bezzina Wettinger S., Mutti A., Otelea M., Seaton A., Felice A. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. Occup. Environ. Med. 2007, 64:673-680.
22. Dick F.D., De Palma G., Ahmadi A., Scott N.W., Prescott G.J., Bennett J., Semple S., Dick S., Counsell C., Mozzoni P., Haites N., Bezzina Wettinger S., Mutti A., Otelea M., Seaton A., Soderkvist P., Felice A., Geoparkinson S.G. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup. Environ. Med. 2007, 64:666-672.
23. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., La Du B. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 2005, 46:1239-1247.
24. Dunn G. Report on an Analytical Study of OP Sheep Dip Reports 2002, Veterinary Medicines Directorate, Surrey.
25. Duysen E.G., Li B., Darvesh S., Lockridge O. Sensitivity of butyrylcholinesterase knockout mice to (-)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology 2007, 233:60-69.
26. Eaton D.L., Daroff R.B., Autrup H., Bridges J., Buffler P., Costa L.G., Coyle J., McKhann G., Mobley W.C., Nadel L., Neubert D., Schulte-Hermann R., Spencer P.S. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit. Rev. Toxicol. 2008, 28(Suppl. 2):1-125.
27. Emahazion T., Jobs M., Howell W.M., Siegfried M., Wyoni P.-I., Prince J., Brookes A.J. Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways. Gene 1999, 238:315-324.
28. Fletcher T., MacLehose R., Hurley F., Cherrie J., Cowie H., Jamal G., Julu P. SHAPE: Survey of Health and Pesticide Exposure The Telephone Survey 2005, http://randd.defra.gov.uk/Document.aspx?Document=VM0299_2606_TRP.doc.
29. Food Environment Research Agency Pesticide Usage Statistics 2009, http://pusstats.csl.gov.uk/index.cfm.
30. Fujioka K., Casida J.E. Glutathione S-transferase conjugation of organophosphorus pesticides yields S-phospho-, S-aryl-, and S-alkylglutathione derivatives. Chem. Res. Toxicol. 2007, 20:1211-1217.
31. Furlong C.E. Genetic variability in the cytochrome P450-Paraoxonase 1 (PON1) pathway for detoxification of organophosphorus compounds. J. Biochem. Mol. Toxicol. 2007, 21:197-205.
32. Furlong C.E., Cole T.B., Jarvik G.P., Costa L.G. Pharmacogenomic considerations of the paraoxonase polymorphisms. Pharmacogenomics 2002, 3:341-348.
33. Gallo M.A., Lawryk N.J. Organic phosphorus pesticides. Handbook of Pesticide Toxicology 1991, vol. 2:917-1053. Academic Press, London.
34. Geldmacher M., von Mallinckrodt M., Diepgen T.L. The human serum paraoxonase-polymorphism and specificity. Toxicol. Environ. Chem. 1988, 18:79-196.
35. Hatjian B.A., Mutch E., Williams F.M., Blain P.G., Edwards J.W. Cytogenetic response without changes in peripheral cholinesterase enzymes following exposure to a sheep dip containing diazinon in vivo and in vitro. Mutat. Res. 2000, 472:85-92.
36. Hernandez A.F., Mackness B., Rodrigo L., Lopez O., Pla A., Gil F., Durrington P.N., Pena G., Parron T., Serrano J.L., Mackness M.I. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure. Hum. Exp. Toxicol. 2003, 22:565-574.
37. Hodgson E., Rose R.L. Organophosphorous chemicals: potent inhibitors of the human metabolism of steroid hormones and xenobiotics. Drug Metab. Rev. 2006, 38:149-162.
38. Hosokawa M. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules 2008, 13:412-431.
39. Hosokawa M., Endo T., Fujisawa M., Hara S., Iwata N., Satp Y., Satoh T. Interindividual variation in carboxylesterase levels in human liver microsomes. Drug Metab. Dispos. 1995, 23:1022-1027.
40. Jokanovic M. Biotransformation of organophosphorus compounds. Toxicology 2001, 166:139-160.
41. Kappers W.A., Edwards R.J., Murray S., Boobis A.R. Diazinon is activated by CYP2C19 in human liver. Toxicol. Appl. Pharmacol. 2001, 177:68-76.
42. Organophosphates and Health 2001, Imperial College Press, London. L. Karalliedde, S. Feldman, J. Henry, T. Marrs (Eds.).
43. Handbook of Pesticide Toxicology 2001, Academic Press, London. 2nd ed. R.I. Krieger (Ed.).
44. Lee B.W., London L., Paulauskis J., Myers J., Christiani D.C. Association between human paraoxonase gene polymorphism and chronic symptoms in pesticide-exposed workers. J. Occup. Environ. Med. 2003, 45:118-122.
45. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 2005, 70:1673-1684.
46. Li W.-F., Costa L.G., Richter R.J., Hagen T., Shih D.M., Tward A., Lusis A.J., Furlong C.E. Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphorous compounds. Pharmacogenetics 2000, 10:767-779.
47. Liddell J.S. Sheep ectoparasite use in the UK 1993, 1997 and 1999. Proceedings of the 5th International Sheep Veterinary Congress 2000, Stellenbosch University, Stellenbosch.
48. Lu C., Bravo R., Caltabiano L.M., Irish R.M., Weerasekera G., Barr D.B. The presence of dialkylphosphates in fresh fruit juices: implication for organophosphorus pesticide exposure and risk assessments. J. Toxicol. Environ. Health 2005, 68:209-227.
49. Lu C., Toepel K., Irish R., Fenske R.A., Barr D.B., Bravo R. Organic diets significantly lower children's dietary exposure to organophosphorous pesticides. Environ. Health Perspect. 2006, 114:260-263.
50. Mackness B., Durrington P., Povey A.C., Thomson S., Middleton S., Dippnall M., Mackness M., Smith A.R., Cherry N.M. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics 2003, 13:81-88.
51. Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington P.N. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br. J. Pharmacol. 1997, 122:265-268.
52. Morahan J.M., Yu B., Trent R.J., Pamphlett R. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 2007, 28:532-540.
53. Moreno-Banda G., Blacno-Munoz J., Lacasana M., Rothenberg S.J., Aguilar-Garduno C., Gamboa R., Perez-Mendez O. Maternal exposure to floricultural work during pregnancy, PON1 Q192R polymorphisms and the risk of low birth weight. Sci. Total Environ. 2009, 10.1016/j.scitotenv.2009.06.033.
54. Moretto A., Lotti M. Monitoring occupational exposures to organophosphorus compounds. Organophosphates and Health 2001, 407-429. Imperial College Press, London. L. Karalliedde, S. Feldman, J. Henry, T. Marrs (Eds.).
55. Mutch E., Daly A.K., Williams F.M. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver. Drug Metab. Dispos. 2007, 35:315-320.
56. Mutch E., Williams F.M. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology 2006, 224:22-32.
57. Niven K., Scott A.J., Hagen S., Waclawski E.R., Lovett M.R., Cherrie B., Bodsworth P.L., Robertson A., Elder A., Cocker I., Nutley B., Roff M. Occupational Hygiene Assessment of Sheep Dipping Practices and Processes. TM/93/03 1993, Institute of Occupational Medicine, Edinburgh.
58. O'Leary K.A., Edwards R.J., Town M.M., Boobis A.R. Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon. Pharmacogenet. Genomics 2005, 15:51-60.
59. Peeples E.S., Schopfer L.M., Duysen E.G., Spaulding R., Voelker T., Thompson C.M., Lockridge O. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol. Sci. 2005, 83:303-312.
60. Perez-Herrera N., Polanco-Minaya H., Salazar-Arredondo E., Solis-Heredia M.J., Hernandez-Ochoa I., Rojas-Garcia E., Alvarado-Mejia J., Borja-Aburto V.H., Quintanilla-Vega B. PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico. Toxicol. Appl. Pharmacol. 2008, 230:261-268.
61. Povey A.C., Mackness M.I., Durrington P.N., Dippnall M., Smith A.E., Mackness B., Cherry N.M. Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep. Occup. Med. 2005, 55:282-286.
62. Povey A.C., Jury F., Dippnall M., Smith T., Thomson S., Mackness B., Mackness M., Durrington P., Cherry N.M. GST, CYP and PON1 polymorphisms in farmers attributing ill-health to organophosphate containing sheep-dip. Biomarkers 2007, 12:188-202.
63. Povey, A.C., Rees, H.G., Thompson, J.P., Karalliedde, L., 2010. Prospective cohort study of sheep dip exposure and 'dipper's flu'. HSE Res. Rep. 775, http://www.hse.gov.uk/research/rrpdf/rr775.pdf.
64. Rees H. Exposure to sheep dip and the incidence of acute symptoms in a group of Welsh sheep farmers. Occup. Environ. Med. 1996, 53:258-263.
65. Richter R.J., Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999, 9:745-753.
66. Richter R.J., Jarvik G.P., Furlong C.E. Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol. Appl. Pharmacol. 2009, 235:1-9.
67. Ross M.K., Crow J.A. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. J. Biochem. Mol. Toxicol. 2007, 21:187-196.
68. Royal College of Physicians of London and the Royal College of Psychiatrists Organophosphate Sheep Dip: Clinical Aspects of Long Term Low-dose Exposure 1998, Royal College of Physicians of London and the Royal College of Psychiatrists, London.
69. Sams C., Cocker J., Lennard M.S. Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome p450s (CYP). Xenobiotica 2004, 34:861-873.
70. Sanghani S.P., Sanghani P.C., Schiel M.A., Bosron W.F. Human carboxylesterases: an update on CES1, CES2 and CES3. Protein Pept. Lett. 2009, 16:1207-1214.
71. Searles Nielsen S., Mueller B.A., De Roos A.J., Viernes H.-M.A., Farin F.M., Checkoway H. Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase. Environ. Health Perspect. 2005, 113:909-913.
72. Shapira M., Tur-Kaspa I., Bosgraaf L., Livni N., Grant A.D., Grisaru D., Korner M., Ebsteiin R.P., Soreq H. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 2000, 9:1273-1281.
73. Shih D.M., Gu L., Xia Y.-R., Navab M., Li W.-F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., Lusis A.J. Mice lacking serum paroxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998, 394:284-287.
74. Solomon C., Poole J., Palmer K.T., Peveler R., Coggon D. Neuropsychiatric symptoms in past users of sheep dip and other pesticides. Occup. Environ. Med. 2007, 64:259-266.
75. Tang J., Cao Y., Rose R.L., Brimfield A.A., Dai D., Goldtsein J.A., Hodgson E. Metabolism of chlorpyrifos by human cytochrome p450 isoforms and human, mouse and rat liver microsomes. Drug Metab. Dispos. 2001, 29:1201-1204.
76. Tarry D.W. Progress in warble fly eradication. Parasitol. Today 1986, 2:111-116.
77. Taylor M.C., Le Couteur D.C., Mellick G.D., Board P.B. Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population. J. Neural Transm. 2000, 107:979-983.
78. Tiffany-Castiglioni E., Venkatraj V., Qian Y. Genetic polymorphisms and mechanisms of neurotoxicity: overview. Neurotoxicology 2005, 26:641-649.
79. Timchalk C., Kousba A., Poet T.S. Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model. Toxicol. Lett. 2002, 135(2002):51-59.
80. Trainor M., Mason H., Cocker J., Chambers H., Guiver R., Wright S. Risk Assessment for Acute Toxicity from Sheep Ectoparasite Treatments, Including Organophosphates (OP's) Used in Plunge Dipping. HSL/2002/26 2002, Health and Safety Laboratory, Sheffield.
81. Veterinary Medicines Directorate Veterinary Medicinal Products (Dips, Injectables, Pour-ons, Sprays and Drenches) Authorised in the UK for Use Against Ectoparasites in Sheep 2009, Veterinary Medicines Directorate, Surrey.
82. Veterinary Products Committee Annual Report for 2000 2000, http://www.vpc.gov.uk/Public/AR/vpcar00.pdf.
83. Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 2003, 33:477-485.
84. Wolff M.S., Engel S., Berkowitz G., Teitelbaum S., Siskind J., Barr D.B., Wetmur J. Prenatal pesticide and PCB exposures and birth outcomes. Pediatr. Res. 2007, 61:243-250.